FDA regulatory considerations for oncology drug development.

Saved in:
Bibliographic Details
Title: FDA regulatory considerations for oncology drug development.
Authors: Moon, Hanlim1 hanlim.moon@medirama.co.kr, Zang, Dae Young2, Ryu, Min‐Hee3, Seo, YeonSook1, Oh, Bitna1, Hwang, Sunjin1, Farrand, Lee1,4
Source: Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-4. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179046786
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: FDA regulatory considerations for oncology drug development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Moon%2C+Hanlim%22">Moon, Hanlim</searchLink><relatesTo>1</relatesTo><i> hanlim.moon@medirama.co.kr</i><br /><searchLink fieldCode="AR" term="%22Zang%2C+Dae+Young%22">Zang, Dae Young</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Ryu%2C+Min‐Hee%22">Ryu, Min‐Hee</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Seo%2C+YeonSook%22">Seo, YeonSook</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Oh%2C+Bitna%22">Oh, Bitna</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hwang%2C+Sunjin%22">Hwang, Sunjin</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Farrand%2C+Lee%22">Farrand, Lee</searchLink><relatesTo>1,4</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pharmacology+Research+%26+Perspectives%22">Pharmacology Research & Perspectives</searchLink>. Aug2024, Vol. 12 Issue 4, p1-4. 4p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179046786
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/prp2.1254
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 1
    Titles:
      – TitleFull: FDA regulatory considerations for oncology drug development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moon, Hanlim
      – PersonEntity:
          Name:
            NameFull: Zang, Dae Young
      – PersonEntity:
          Name:
            NameFull: Ryu, Min‐Hee
      – PersonEntity:
          Name:
            NameFull: Seo, YeonSook
      – PersonEntity:
          Name:
            NameFull: Oh, Bitna
      – PersonEntity:
          Name:
            NameFull: Hwang, Sunjin
      – PersonEntity:
          Name:
            NameFull: Farrand, Lee
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 20521707
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Pharmacology Research & Perspectives
              Type: main
ResultId 1